Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAO 2007: Updates on Presby-IOLs and AMD Therapies

Executive Summary

The buzz at this year's annual meeting of the American Academy of Ophthalmology focused on two things: the presbyopia-correcting intraocular lens market, and the controversy surrounding the drugs Lucentis and Avastin for treating wet age-related macular degeneration.

You may also be interested in...



Cataract and Refractive Surgery: Hoping For a Rebound

April's annual meeting of the American Society of Cataract and Refractive Surgery took place against of the darkest market backdrops in memory. The mood at ASCRS was not all gloom and doom, however. Cataract and refractive surgery technology continues to advance and a number of new product were introduced at the meeting.

ESCRS: Zooming in on Vision Innovations

At this year's meeting of the Congress of the European Society of Cataract and Refractive Surgeons, market leaders made headlines with news of joint ventures in refractive surgery, new product launches and re-launches, and other glimpses into the future of vision correction technology.

ESCRS: Zooming in on Vision Innovations

At this year's meeting of the Congress of the European Society of Cataract and Refractive Surgeons, market leaders made headlines with news of joint ventures in refractive surgery, new product launches and re-launches, and other glimpses into the future of vision correction technology.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT035130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel